REGULUS THERAPEUTICS

regulus-therapeutics-logo

Regulus Therapeutics Is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. The discovery of MicroRNA in humans is one of the most exciting scientific breakthroughs in the last decade. MicroRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteins but instead regulate gene expression. It was founded in 2007 and is headquartered in Carlsbad, California.

#SimilarOrganizations #People #Financial #Event #Website #More

REGULUS THERAPEUTICS

Social Links:

Industry:
Biotechnology Genetics Health Care Therapeutics

Founded:
2007-09-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.regulusrx.com

Total Employee:
51+

Status:
Active

Contact:
858-202-6300

Email Addresses:
[email protected]

Total Funding:
361.4 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt WordPress Font Awesome Nginx Microsoft Exchange Online


Similar Organizations

xilio-therapeutics-logo

Xilio Therapeutics

Xilio Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

ansun-biopharma-logo

Ansun BioPharma

Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.

ascenta-therapeutics-logo

Ascenta Therapeutics

Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.

ayala-pharmaceuticals-logo

Ayala Pharmaceuticals

Ayala Pharmaceuticals a clinical-stage biopharmaceutical company focused on developing and commercializing small molecule therapeutics.

bellicum-pharmaceuticals-logo

Bellicum Pharmaceuticals

Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that is driving the future of cellular immuno-oncology (IO).

biotheryx-logo

BioTheryX

BioTheryX is a clinical-stage biopharmaceutical company that focuses on the development of therapies for hematological malignancies.

brooklyn-immunotherapeutics-logo

Brooklyn ImmunoTherapeutics

Brooklyn ImmunoTherapeutics is a clinical=stage biopharmaceutical company discovers and develops a novel cytokine-based therapy.

cascadian-therapeutics-logo

Cascadian Therapeutics

Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.

cohbar-logo

CohBar

CohBar is a clinical-stage biotechnology company that focuses on the research and development of mitochondria based therapeutics.

crestone-logo

Crestone

Crestone is a clinical stage biopharmaceutical company focused on inventing and developing novel mechanism.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

eloxx-logo

Eloxx

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.

fulgent-therapeutics-logo

Fulgent Therapeutics

Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.

gossamer-bio-logo

Gossamer Bio

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

idun-pharmaceuticals-logo

Idun Pharmaceuticals

IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control

kind-pharmaceutical-logo

Kind Pharmaceutical

Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs.

liquidia-technologies-logo

Liquidia Technologies

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

monopar-logo

Monopar

Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.

motif-biosciences-logo

Motif BioSciences

Motif BioSciences, a population genetics company, focuses on the genetic causes of major diseases usingย human genetic data from individuals.

rafael-holdings-logo

Rafael Holdings

Rafael Holdings is a company focused on the development of novel cancer therapies.

raptor-pharmaceuticals-logo

Raptor Pharmaceuticals

Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop and commercialize life-altering therapeutics.

renova-therapeutics-logo

Renova Therapeutics

Renova Therapeutics is an industry leader in the emerging field of gene therapy, pursuing the development of treatments.

seres-therapeutics-logo

Seres Therapeutics

Seres Therapeutics is a microbiome therapeutics company.

stemline-therapeutics-logo

Stemline Therapeutics

Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.

stemtek-therapeutics-logo

StemTek Therapeutics

StemTek is a biopharmaceutical company focused on the research and development of drugs for cancer treatment.

tetra-therapeutics-logo

Tetra Therapeutics

Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products.

vanda-pharmaceuticals-logo

Vanda Pharmaceuticals

Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies.

vical-logo

Vical

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.

zymenex-logo

Zymenex

Zymenex is a Scandinavian biopharmaceutical company focused on the development and commercialization of novel enzyme replacement therapies


Current Advisors List

barry-greene_image

Barry Greene Board Member @ Regulus Therapeutics
Board_member
2009-01-01

william-rastetter_image

William Rastetter Member of the Board of Directors @ Regulus Therapeutics
Board_member

stelios-papadopoulos_image

Stelios Papadopoulos Member of the Board of Directors @ Regulus Therapeutics
Board_member

Current Employees Featured

jay-hagan_image

Jay Hagan
Jay Hagan President, CEO & Director @ Regulus Therapeutics
President, CEO & Director
2017-05-01

not_available_image

Peter S. Linsley
Peter S. Linsley CTO @ Regulus Therapeutics
CTO

simos-simeonidis_image

Simos Simeonidis
Simos Simeonidis Director Board Of Directors @ Regulus Therapeutics
Director Board Of Directors
2019-06-01

cris-calsada_image

Cris Calsada
Cris Calsada Chief Financial Officer @ Regulus Therapeutics
Chief Financial Officer
2019-08-01

mohammad-ahmadian_image

Mohammad Ahmadian
Mohammad Ahmadian VP of Chemistry & Pharmaceutical Development @ Regulus Therapeutics
VP of Chemistry & Pharmaceutical Development
2021-12-01

brian-campion_image

Brian Campion
Brian Campion Vice President, Business Development @ Regulus Therapeutics
Vice President, Business Development
2020-07-01

denis-drygin_image

Denis Drygin
Denis Drygin Chief Scientific Officer @ Regulus Therapeutics
Chief Scientific Officer
2020-08-01

amin-kamel_image

Amin Kamel
Amin Kamel Vice President of DMPK @ Regulus Therapeutics
Vice President of DMPK
2022-01-01

Stock Details


Company's stock symbol is NASDAQ:RGLS

Investors List

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Post-IPO Equity - Regulus Therapeutics

federated-kaufmann-fund-2_image

Federated Kaufmann Fund

Federated Kaufmann Fund investment in Post-IPO Equity - Regulus Therapeutics

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Post-IPO Equity - Regulus Therapeutics

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Debt - Regulus Therapeutics

sanofi_image

Sanofi

Sanofi investment in Funding Round - Regulus Therapeutics

Key Employee Changes

Date New article
2022-06-02 Regulus Therapeutics Names VP
2021-12-03 Regulus Therapeutics Names VP

Official Site Inspections

http://www.regulusrx.com

  • Host name: 234.80.154.104.bc.googleusercontent.com
  • IP address: 104.154.80.234
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Regulus Therapeutics" on Search Engine